Nifty
:
22570.35
Sensex
:
74339.44
167.95 (0.75%)
486.50 (0.66%)
Nifty
Sensex
:
:
22570.35
74339.44
167.95 (0.75%)
486.50 (0.66%)

SMS Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

Rating :
56/99

BSE: 532815 | NSE: SMSPHARMA

NSE BSE
208.35
25-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  209.15
  •  213.00
  •  208.00
  •  209.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  204037
  •  427.88
  •  219.40
  •  79.40

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,766.69
  • 45.57
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,009.38
  • 0.14%
  • 3.60

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 64.67%
  • 1.75%
  • 27.93%
  • FII
  • DII
  • Others
  • 0.17%
  • 1.98%
  • 3.50%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.05
  • 2.35
  • -2.50

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.44
  • -9.55
  • -14.75

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -14.86
  • -37.73
  • -60.07

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.99
  • 12.52
  • 14.47

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.11
  • 1.98
  • 2.19

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.67
  • 11.67
  • 14.08

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
161.48
148.80
8.52%
166.64
159.43
4.52%
135.34
64.39
110.19%
149.43
60.92
145.29%
Expenses
132.48
130.29
1.68%
138.82
145.87
-4.83%
109.16
65.20
67.42%
126.19
65.36
93.07%
EBITDA
29.00
18.51
56.67%
27.82
13.56
105.16%
26.18
-0.81
-
23.24
-4.44
-
EBIDTM
17.96%
12.44%
16.69%
8.51%
19.35%
-1.26%
15.55%
-7.29%
Other Income
1.49
2.21
-32.58%
0.81
0.61
32.79%
0.51
0.80
-36.25%
1.26
0.43
193.02%
Interest
5.95
5.94
0.17%
5.57
5.24
6.30%
6.32
4.85
30.31%
5.88
4.34
35.48%
Depreciation
8.01
8.13
-1.48%
7.90
8.09
-2.35%
7.69
7.93
-3.03%
7.97
7.97
0.00%
PBT
16.53
6.67
147.83%
15.16
0.84
1,704.76%
12.68
-12.79
-
10.63
-16.33
-
Tax
4.24
1.39
205.04%
3.11
0.11
2,727.27%
3.87
-2.60
-
2.57
-25.23
-
PAT
12.29
5.28
132.77%
12.05
0.73
1,550.68%
8.81
-10.19
-
8.07
8.90
-9.33%
PATM
7.61%
3.55%
7.23%
0.46%
6.51%
-15.83%
5.40%
14.61%
EPS
1.36
0.44
209.09%
1.39
-0.24
-
1.10
-1.51
-
0.73
0.73
0.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Net Sales
612.89
522.05
519.87
563.18
411.95
464.91
464.93
445.49
611.53
199.84
Net Sales Growth
41.37%
0.42%
-7.69%
36.71%
-11.39%
0.00%
4.36%
-27.15%
206.01%
 
Cost Of Goods Sold
350.05
335.81
275.45
340.00
246.36
292.71
289.90
295.85
385.15
109.95
Gross Profit
262.84
186.23
244.43
223.18
165.59
172.20
175.03
149.64
226.38
89.88
GP Margin
42.88%
35.67%
47.02%
39.63%
40.20%
37.04%
37.65%
33.59%
37.02%
44.98%
Total Expenditure
506.65
467.49
405.26
442.04
331.92
374.77
371.59
370.35
522.32
150.38
Power & Fuel Cost
-
36.73
32.58
23.31
18.99
21.75
22.57
18.23
33.81
8.95
% Of Sales
-
7.04%
6.27%
4.14%
4.61%
4.68%
4.85%
4.09%
5.53%
4.48%
Employee Cost
-
55.04
51.02
41.17
39.35
35.59
32.80
26.92
38.11
5.81
% Of Sales
-
10.54%
9.81%
7.31%
9.55%
7.66%
7.05%
6.04%
6.23%
2.91%
Manufacturing Exp.
-
22.03
25.80
16.28
14.89
13.29
12.14
10.35
37.94
7.31
% Of Sales
-
4.22%
4.96%
2.89%
3.61%
2.86%
2.61%
2.32%
6.20%
3.66%
General & Admin Exp.
-
12.78
15.32
14.93
8.05
8.69
8.45
9.00
10.51
3.36
% Of Sales
-
2.45%
2.95%
2.65%
1.95%
1.87%
1.82%
2.02%
1.72%
1.68%
Selling & Distn. Exp.
-
3.82
3.42
5.09
3.70
2.25
4.81
9.67
15.99
10.41
% Of Sales
-
0.73%
0.66%
0.90%
0.90%
0.48%
1.03%
2.17%
2.61%
5.21%
Miscellaneous Exp.
-
1.27
1.67
1.25
0.58
0.49
0.91
0.33
0.80
4.59
% Of Sales
-
0.24%
0.32%
0.22%
0.14%
0.11%
0.20%
0.07%
0.13%
2.30%
EBITDA
106.24
54.56
114.61
121.14
80.03
90.14
93.34
75.14
89.21
49.46
EBITDA Margin
17.33%
10.45%
22.05%
21.51%
19.43%
19.39%
20.08%
16.87%
14.59%
24.75%
Other Income
4.07
4.89
5.20
3.45
5.11
3.40
2.39
1.45
3.61
3.03
Interest
23.72
21.98
19.16
11.19
12.32
11.92
15.48
15.82
17.11
8.23
Depreciation
31.57
32.13
32.15
22.28
22.07
19.27
19.90
19.18
19.43
4.58
PBT
55.00
5.35
68.50
91.12
50.76
62.35
60.35
41.58
56.27
39.67
Tax
13.79
1.47
0.62
30.16
18.07
20.90
19.89
5.97
14.63
14.20
Tax Rate
25.07%
27.48%
0.91%
33.10%
35.60%
33.52%
32.96%
14.36%
26.00%
35.80%
PAT
41.22
3.88
67.88
60.96
32.69
41.45
40.45
35.61
41.64
25.47
PAT before Minority Interest
41.22
3.88
67.88
60.96
32.69
41.45
40.45
35.61
41.64
25.47
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
6.73%
0.74%
13.06%
10.82%
7.94%
8.92%
8.70%
7.99%
6.81%
12.75%
PAT Growth
773.31%
-94.28%
11.35%
86.48%
-21.13%
2.47%
13.59%
-14.48%
63.49%
 
EPS
4.87
0.46
8.01
7.20
3.86
4.89
4.78
4.20
4.92
3.01

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Shareholder's Funds
460.53
470.29
410.53
348.24
321.92
284.49
254.74
293.60
192.08
Share Capital
8.47
8.47
8.47
8.47
8.47
8.47
8.47
8.47
10.00
Total Reserves
452.06
461.82
402.06
339.77
313.45
276.02
246.28
285.14
182.07
Non-Current Liabilities
164.17
192.73
206.26
114.47
94.35
96.58
91.41
161.56
88.21
Secured Loans
119.93
148.30
146.21
67.02
61.01
70.20
73.02
109.58
65.92
Unsecured Loans
1.20
1.20
1.20
1.20
1.20
1.20
1.20
3.64
6.95
Long Term Provisions
1.40
1.57
1.84
1.73
1.52
2.18
1.35
3.43
0.00
Current Liabilities
254.97
211.48
211.43
154.21
156.05
134.29
156.00
200.43
49.03
Trade Payables
113.15
72.86
65.44
44.49
47.70
39.27
66.75
84.40
23.86
Other Current Liabilities
46.93
54.69
58.31
38.84
23.32
22.91
19.95
40.37
0.33
Short Term Borrowings
93.79
67.91
70.86
61.16
70.81
58.40
59.76
72.75
0.00
Short Term Provisions
1.10
16.02
16.82
9.72
14.22
13.71
9.54
2.90
24.84
Total Liabilities
879.67
874.50
828.22
616.92
572.32
515.36
502.15
655.59
329.32
Net Block
412.02
437.99
457.36
280.49
281.26
279.26
290.45
370.35
68.84
Gross Block
575.55
569.62
558.80
360.77
339.57
318.34
309.63
500.81
96.16
Accumulated Depreciation
163.53
131.63
101.44
80.29
58.31
39.08
19.18
130.46
27.32
Non Current Assets
468.96
482.45
502.88
389.13
351.22
334.04
335.80
408.04
83.85
Capital Work in Progress
33.19
11.00
6.74
42.12
18.30
8.20
7.76
12.80
15.02
Non Current Investment
10.52
21.53
27.30
25.81
26.99
28.38
29.10
20.51
0.00
Long Term Loans & Adv.
10.70
9.32
9.10
38.47
22.55
16.19
6.58
4.37
0.00
Other Non Current Assets
2.54
2.61
2.38
2.25
2.13
2.01
1.90
0.00
0.00
Current Assets
410.70
392.05
325.33
227.78
221.09
181.32
166.36
247.55
233.89
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.03
Inventories
223.50
251.10
137.79
129.20
136.40
107.48
92.52
112.68
49.57
Sundry Debtors
148.35
48.52
105.68
48.77
26.02
24.15
21.32
61.09
59.98
Cash & Bank
7.47
46.66
40.51
9.65
14.88
12.71
12.37
15.08
95.71
Other Current Assets
31.39
6.39
19.18
20.96
43.79
36.98
40.15
58.70
28.60
Short Term Loans & Adv.
25.39
39.39
22.17
19.20
17.06
14.89
11.67
23.49
26.79
Net Current Assets
155.74
180.57
113.90
73.57
65.04
47.03
10.36
47.13
184.86
Total Assets
879.66
874.50
828.21
616.91
572.31
515.36
502.16
655.59
329.31

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Cash From Operating Activity
22.45
45.06
90.45
39.71
49.76
31.81
73.47
61.22
14.33
PBT
5.35
68.50
91.12
50.76
62.35
60.35
41.58
56.27
39.67
Adjustment
52.99
49.86
27.76
28.66
26.81
31.08
31.58
28.14
18.09
Changes in Working Capital
-31.29
-58.38
-12.38
-27.60
-26.02
-48.48
9.40
-1.17
-29.61
Cash after chg. in Working capital
27.05
59.98
106.50
51.82
63.14
42.95
82.56
83.24
28.16
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-4.60
-14.92
-16.05
-12.10
-13.38
-11.14
-9.09
-22.02
-5.60
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-29.69
-27.15
-151.59
-42.56
-34.67
-16.58
-38.96
-96.72
-31.70
Net Fixed Assets
-28.12
-15.08
-162.65
-45.02
-31.33
-9.15
128.49
-346.44
Net Investments
-0.10
0.00
0.00
0.00
0.00
-8.02
-15.71
-17.94
Others
-1.47
-12.07
11.06
2.46
-3.34
0.59
-151.74
267.66
Cash from Financing Activity
-31.97
-11.75
92.02
-2.40
-12.92
-14.89
-33.19
44.34
106.55
Net Cash Inflow / Outflow
-39.20
6.16
30.88
-5.25
2.17
0.35
1.32
8.84
89.18
Opening Cash & Equivalents
46.58
40.42
9.54
14.80
12.63
12.29
11.25
2.41
6.53
Closing Cash & Equivalent
7.38
46.58
40.42
9.54
14.80
12.63
12.29
11.25
95.71

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Book Value (Rs.)
54.40
55.56
48.50
41.14
38.03
33.61
30.09
34.68
18.05
ROA
0.44%
7.97%
8.44%
5.50%
7.62%
7.95%
6.15%
8.46%
7.73%
ROE
0.83%
15.41%
16.07%
9.76%
13.67%
15.00%
12.99%
17.57%
14.11%
ROCE
3.79%
12.60%
17.62%
13.06%
16.57%
18.17%
12.73%
19.54%
18.91%
Fixed Asset Turnover
0.97
0.98
1.32
1.29
1.53
1.59
1.12
2.11
2.24
Receivable days
65.01
50.80
46.40
30.27
18.23
16.66
33.12
35.09
101.66
Inventory Days
156.71
128.12
80.21
107.49
88.61
73.28
82.47
47.02
84.02
Payable days
101.09
91.63
59.01
46.62
40.24
46.81
71.90
36.96
57.46
Cash Conversion Cycle
120.64
87.30
67.61
91.14
66.60
43.12
43.69
45.14
128.22
Total Debt/Equity
0.55
0.55
0.61
0.44
0.45
0.51
0.59
0.70
0.40
Interest Cover
1.24
4.57
9.14
5.12
6.23
4.90
3.63
4.29
5.82

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011
FY 2010

News Update:


  • SMS Pharmaceuticals - Quarterly Results
    8th Feb 2024, 19:04 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.